Shanghai Henlius Biotech H (2696) Stock | Share Price | News
2696 · Health Care ·
China
Shanghai Henlius Biotech H (2696) is a company in the Health Care sector, based in China. The stock is held in 1 ETF we track. That means you can hold Shanghai Henlius Biotech H indirectly and diversified through an ETF savings plan.
Low ETF coverage: 1 of the 95 ETFs we cover holds Shanghai Henlius Biotech H, spread across one index. That places it among the least widely held names in index funds — of the 4,278 stocks we cover, none sits in fewer ETFs.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| IS3N | msci-em-imi | 0.00 % |
Want to know how much Shanghai Henlius Biotech H overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Shanghai Henlius Biotech H — the figure counts the ETFs holding both.
- Shandong Weigao GP Medical Polymer1066 · 1 shared ETFs
- Jinxin Fertility Group1951 · 1 shared ETFs
- Ssy Group Ltd.2005 · 1 shared ETFs
- Microport Neurotech Corp.2172 · 1 shared ETFs
- Luye Pharma Group2186 · 1 shared ETFs
- Genfleet Therapeutics (Shanghai)2595 · 1 shared ETFs
- Genertec Universal Medical Group2666 · 1 shared ETFs
- China Shineway Pharmaceutical Ltd.2877 · 1 shared ETFs
Latest Investment Intelligence News: Stocks
· Risk-onArbitrum is the day's top gainer, up 12.4% – September 2, 2026
· Risk-offFilecoin surges 14.2% – September 1, 2026
· MixedArbitrum climbs 29.8% – August 31, 2026
· Risk-offCrypto, commodities & FX this week: Arbitrum +41.3% · August 24–28, 2026
· Risk-offThe week in markets: DAX lags the week (-2.2%) · August 24–28, 2026